What Researchers Did
The researchers looked back at 62 patients treated with hyperbaric oxygen for bladder bleeding that developed after radiation therapy, and checked how many improved.
What They Found
This retrospective review of patients treated at one institution reported that 49 of 57 patients with available data (86%) had complete resolution or marked improvement of blood in the urine after hyperbaric oxygen treatment. Patients received an average of 33 treatments (range 9 to 68), and follow-up ranged from 10 to 120 months. Of the 8 patients who did not improve, 4 received fewer than 40 treatments and 7 stopped treatment early (medical conditions in 4, claustrophobia in 2, temporary resolution of symptoms in 1). The main underlying cancers were prostate cancer (81%) and bladder cancer (10%).
What This Means for Canadian Patients
For people whose bladder bleeding followed pelvic radiation, this study reports that most patients with available data improved after hyperbaric oxygen. The authors describe it as an efficacious option for patients in whom other management has failed. Because the study has no comparison group, it cannot show that the treatment caused the improvement. Anyone considering it should talk with their own physician.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract describes a single-institution review of past patient records with no comparison group, and results were available for only 57 of the 62 patients treated, so the findings cannot prove that hyperbaric oxygen caused the improvement.